Skip to main content
main-content

01.12.2013 | Research article | Ausgabe 1/2013 Open Access

BMC Cancer 1/2013

Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

Zeitschrift:
BMC Cancer > Ausgabe 1/2013
Autoren:
Minhua Rong, Gang Chen, Yiwu Dang
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2407-13-21) contains supplementary material, which is available to authorized users.
Minhua Rong, Gang Chen contributed equally to this work.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MHR, GC and YWD designed the study, performed statistical analysis and wrote the manuscript; GC performed the majority of experiments; YWD collected and cut the FFPE samples and sorted out pathological information. All authors read and approved the final manuscript.

Abstract

Background

MiR-221 is over-expressed in human hepatocellular carcinoma (HCC), but its clinical significance and function in HCC remains uncertain. The aim of the study was to investigate the relationship between miR-221 overexpression and clinicopathological parameters in HCC formalin-fixed paraffin-embedded (FFPE) tissues, and the effect of miR-221 inhibitor and mimic on different HCC cell lines in vitro.

Methods

MiR-221 expression was detected using real time RT-qPCR in FFPE HCC and the adjacent noncancerous liver tissues. The relationship between miR-221 level and clinicopathological features was also analyzed. Furthermore, miR-221 inhibitor and mimic were transfected into HCC cell lines HepB3, HepG2 and SNU449. The effects of miR-221 on cell growth, cell cycle, caspase activity and apoptosis were also investigated by spectrophotometry, fluorimetry, fluorescence microscopy and flow cytometry, respectively.

Results

The relative expression of miR-221 in clinical TNM stages III and IV was significantly higher than that in the stages I and II. The miR-221 level was also upregulated in the metastatic group compared to the nonmetastatic group. Furthermore, miR-221 over-expression was related to the status of tumor capsular infiltration in HCC clinical samples. Functionally, cell growth was inhibited, cell cycle was arrested in G1/S-phase and apoptosis was increased by miR-221 inhibitor in vitro. Likewise, miR-221 mimic accelerated the cell growth.

Conclusions

Expression of miR-221 in FFPE tissues could provide predictive significance for prognosis of HCC patients. Moreover, miR-221 inhibitor could be useful to suppress proliferation and induce apoptosis in HCC cells. Thus miR-221 might be a critical targeted therapy strategy for HCC.
Zusatzmaterial
Authors’ original file for figure 1
12885_2012_3609_MOESM1_ESM.tiff
Authors’ original file for figure 2
12885_2012_3609_MOESM2_ESM.tiff
Authors’ original file for figure 3
12885_2012_3609_MOESM3_ESM.tiff
Authors’ original file for figure 4
12885_2012_3609_MOESM4_ESM.tiff
Authors’ original file for figure 5
12885_2012_3609_MOESM5_ESM.tiff
Authors’ original file for figure 6
12885_2012_3609_MOESM6_ESM.tiff
Authors’ original file for figure 7
12885_2012_3609_MOESM7_ESM.tiff
Authors’ original file for figure 8
12885_2012_3609_MOESM8_ESM.tiff
Authors’ original file for figure 9
12885_2012_3609_MOESM9_ESM.tiff
Authors’ original file for figure 10
12885_2012_3609_MOESM10_ESM.tiff
Authors’ original file for figure 11
12885_2012_3609_MOESM11_ESM.tiff
Authors’ original file for figure 12
12885_2012_3609_MOESM12_ESM.tiff
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2013

BMC Cancer 1/2013 Zur Ausgabe

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise